Person-Level Correlates of Nonadherence to Co-Medication in Spanish Heart Transplant Recipients

View at publisher Summarise with VIRAT
Authors: Maria Generosa Crespo-Leiro, Teresa Rosalía Pérez-Castro, Luis Almenar Bonet, Carmen Segura Saint-Gerons, Vicenç Brossa-Loidi, Javier Segovia-Cubero, Carmen Naya-Leira, Raquel López‐Vilella, Amador López‐Granados, Dolores Gil-Alonso, Ana Briceño, Javier Muñiz
+3 more Zulaika Grille-Cancela, Kris Denhaerynck, Sabina De Geest
Cited by: 0
References: 30

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Nonadherence to heart transplantation-related medications involves both immunosuppressant drugs and co-medications; yet the correlates of heart transplantation patients' overall medication nonadherence remain unclear. OBJECTIVES: We aimed to (1) describe nonadherence to both immunosuppressive and co-medication among Spanish heart transplantation patients, (2) to identify individual-level predictors of co-medication nonadherence, and (3) to describe nonadherence to non-pharmacological advice (eg, sun protection, physical activity, alcohol use) and clinical practice patterns of transplant centers. METHODS: ). Correlates of nonadherence to co-medications were derived from the Integrative Model of Behavioral Prediction using self-report instruments, as were non-pharmacological treatment adherence and treatment centers' practice patterns. Supported by causal mapping, multiple logistic regression analysis allowed adjustment for relevant confounders. RESULTS: Nonadherence prevalence was 16.5% for co-medications (range across centers: 7.4%-25.0%), versus 9.4% (range: 2.6%-22.2%) for immunosuppressants. Adherence support varied across centers. Barriers to immunosuppressant nonadherence predicted co-medication nonadherence (odds ratio = 11.80; 95% CI, 2.59-53.69). Nonadherence to non-pharmacological treatments, particularly sunscreen use (59.3%) and physical activity (31.8%), were also common. CONCLUSIONS: Post-heart transplantation co-medication nonadherence surpasses immunosuppressant nonadherence. Barriers to immunosuppressant adherence strongly predict co-medication nonadherence. While no direct causal relationship is clear, immunosuppressant nonadherence may prove useful for identifying patients prone to co-medication nonadherence.

Fields of Study & Subjects

Medication Adherence and Compliance Transplantation: Methods and Outcomes Heart Failure Treatment and Management

Publication details

Journal / source
Western Journal of Nursing Research
Volume
48
Issue
5
Pages
468–478
Publication date
28 March 2026
Language
EN